4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-26-000133
Options or other derivatives
- Chief Executive Officer acquired 151,172 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kelderman Kim Chief Executive Officer | 2026-08-17 | Grant or award · Restricted Stock Units | +57,590 | 57,590 | D: show line 1 in the form | |||||
| Kelderman Kim Chief Executive Officer | 2026-08-17 | Grant or award · Restricted Stock Units | +93,582 | 93,582 | D: show line 2 in the form |
Loading xslF345X06/form4.xml…